Any Solid Tumors Progressed After a Prior Immunotherapy trials recruiting in Ohio

Fewer than 3 recruiting trials found.

All Any Solid Tumors Progressed After a Prior Immunotherapy trials nationally

Cities in Ohio

Recruiting trials in Ohio

• VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
  NCT03556228 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Ohio: Maumee